Addition of simvastatin to carvedilol non responders: A new pharmacological therapy for treatment of portal hypertension
Zeeshan Ahmad Wani, Department of Gastroenterology and Hepatology, Institute of Liver and Biliary Sciences, New Delhi 110070, India
Sonmoon Mohapatra, Department of Internal Medicine, Rutgers Robert Wood Johnson Medical School/Saint Peters University Hospital, New Brunswick, NJ 08901, United States
Afaq Ahmad Khan, Department of Hematology and Oncology, JLNM hospital, Srinagar, Kashmir 190002, India
Ashutosh Mohapatra, Department of Gastroenterology and Hepatology, AMRI Hospitals, Bhubaneswar 751019, India
Ghulam Nabi Yatoo, Department of Gastroenterology and Hepatology, Sher-i-Kashmir Institute of Medical Sciences, Srinagar, Kashmir 190011, India
Author contributions: The work was carries out in collaboration of all authors; Wani ZA designed the study, performed the research and analyzed the data; Wani ZA and Mohapatra S wrote the first draft of the article; Khan AA and Yatoo GN made critical revisions related to important intellectual content of the manuscript; Mohapatra S and Mohapatra A edited and revised the manuscript for final submission.
Institutional review board statement: The study was reviewed and approved by Sher-i-Kashmir Institute of Medical Sciences Medical College, Srinagar, Jammu and Kashmir 190011, India and was conducted in Sher-i-Kashmir Institute of Medical Sciences Medical College, Srinagar and Noora Multispecialty Hospital, Srinagar, Kashmir, India.
Informed consent statement: All included patients gave their informed consent (written or verbal) prior to study inclusion.
Conflict-of-interest statement: The Authors have no conflict of interest.
Data sharing statement: No additional data are available.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Sonmoon Mohapatra, MD, Department of Internal Medicine, Rutgers Robert Wood Johnson Medical School/Saint Peters University Hospital, 254 Easton Ave, New Brunswick, NJ 08901, United States. email@example.com
Received: November 13, 2016
Peer-review started: November 15, 2016
First decision: December 1, 2016
Revised: December 15, 2016
Accepted: January 11, 2017
Article in press: January 14, 2017
Published online: February 18, 2017